A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Active, not recruiting · NCT02344355 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-09-30 | NCT02344355 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bryan Allen | 2 |
| Gateway for Cancer Research | 32 |
| Holden Comprehensive Cancer Center | 8 |
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Holden Comprehensive Cancer Center | Iowa City | United States | 6 |